Neuromove
As the third leading cause of death and the leading cause of long-term disability in the United States, stroke affects approximately 4 million Americans currently living with its debilitating effects. Despite these statistics, according to the National Stroke Association nearly 35% of all stroke victims either recover completely or with only minor impairments through the dedicated efforts of rehabilitation specialists and products.

Through rehabilitation, an individual who has experienced a stroke is empowered to reach the highest possible level of independence and to be as productive as possible. To help patients reach this goal, Zynex Medical has developed the NeuroMove technique, which is designed to increase functionality among stroke victims by teaching the healthy parts of the brain to compensate for the injured areas. With this technique, the NeuroMove offers new hope to patients whose fuctional development may have slowed or ceased by providing state-of-the-art, barrier-breaking tools in the battle toward recovery.

The NeuroMove has achieved success in approximately 90% of cases with patients both achieving and maintaining significant functional improvement. The Neuromove is cleared by the FDA specifically for Stroke Rehab and has been proven effective in many clinical studies. Many stroke and spinal cord injured patients in the US have experienced dramatic results with this device used in the home.

For more information, please visit the NeuroMove web site at www.neuromove.com.

Go back to products page.